Published in Eur J Biochem on October 01, 1996
Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations. J Med Chem (2000) 2.35
Implementation of semi-automated cloning and prokaryotic expression screening: the impact of SPINE. Acta Crystallogr D Biol Crystallogr (2006) 1.56
Identification of a novel human organic anion transporting polypeptide as a high affinity thyroxine transporter. Mol Endocrinol (2002) 1.49
Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors. J Drug Target (1998) 1.46
The structures of thymidine kinase from herpes simplex virus type 1 in complex with substrates and a substrate analogue. Protein Sci (1997) 1.44
The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226. Eur J Pharmacol (1994) 1.43
Biosynthesis of the lantibiotic Pep5. Isolation and characterization of a prepeptide containing dehydroamino acids. Eur J Biochem (1990) 1.40
Action of derivatives of mu-conotoxin GIIIA on sodium channels. Single amino acid substitutions in the toxin separately affect association and dissociation rates. Biochemistry (1992) 1.39
ESAG 6 and 7 products of Trypanosoma brucei form a transferrin binding protein complex. Eur J Cell Biol (1994) 1.25
Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs' lipophilicity and molecular weight. Eur J Pharm Sci (1998) 1.19
The three-dimensional structure of thymidine kinase from herpes simplex virus type 1. FEBS Lett (1995) 1.16
Palmitoylation alters protein activity: blockade of G(o) stimulation by GAP-43. EMBO J (1992) 1.13
Directed evolution of thymidine kinase for AZT phosphorylation using DNA family shuffling. Nat Biotechnol (1999) 1.13
Identification of steroid sulfate transport processes in the human mammary gland. J Clin Endocrinol Metab (2003) 1.13
Molecular dynamics simulation of MHC-peptide complexes as a tool for predicting potential T cell epitopes. Biochemistry (1994) 1.13
Application of high-throughput technologies to a structural proteomics-type analysis of Bacillus anthracis. Acta Crystallogr D Biol Crystallogr (2006) 1.11
Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family. J Pept Sci (2000) 1.07
A fast and inexpensive method for N-terminal fluorescein-labeling of peptides. Bioorg Med Chem Lett (1998) 1.07
Structure and dynamics of micelle-bound neuropeptide Y: comparison with unligated NPY and implications for receptor selection. J Mol Biol (2001) 1.06
From micromolar to nanomolar affinity: a systematic approach to identify the binding site of CGRP at the human calcitonin gene-related peptide 1 receptor. J Med Chem (1998) 1.03
Epitope mapping of the Dermatophagoides pteronyssinus house dust mite major allergen Der p II using overlapping synthetic peptides. Mol Immunol (1991) 1.03
Substrate diversity of herpes simplex virus thymidine kinase. Impact Of the kinematics of the enzyme. J Biol Chem (1999) 1.03
Novel peptide conjugates for tumor-specific chemotherapy. J Med Chem (2001) 1.02
Central vaspin administration acutely reduces food intake and has sustained blood glucose-lowering effects. Diabetologia (2011) 1.02
Molecular cloning, genetic mapping, and developmental expression of bovine POU5F1. Biol Reprod (1999) 1.02
A cyclic AMP response element is involved in retinoic acid-dependent RAR beta 2 promoter activation. Nucleic Acids Res (1992) 1.01
Comparison of the photochemical behavior of four different photoactivatable probes. J Pept Res (1997) 1.00
The first selective agonist for the neuropeptide YY5 receptor increases food intake in rats. J Biol Chem (2000) 1.00
Monitoring of the internalization of neuropeptide Y on neuroblastoma cell line SK-N-MC. Eur J Biochem (2000) 0.99
Biosynthesis of peptide hormones derived from precursor sequences. Curr Med Chem (2004) 0.96
Peptides as carrier for tumor diagnosis and treatment. Curr Med Chem Anticancer Agents (2001) 0.96
A spectrophotometric assay for quantitative determination of kcat of herpes simplex virus type 1 thymidine kinase substrates. Anal Biochem (2001) 0.96
The solution structure of the lantibiotic gallidermin. Biopolymers (1991) 0.96
Drug resistance of herpes simplex virus type 1--structural considerations at the molecular level of the thymidine kinase. Eur J Biochem (1998) 0.95
An analysis of the helix-to-strand transition between peptides with identical sequence. Proteins (2000) 0.94
Role of prohormone convertases in pro-neuropeptide Y processing: coexpression and in vitro kinetic investigations. Biochemistry (1997) 0.93
Molecular dynamics study of a complex between the human histocompatibility antigen HLA-A2 and the IMP58-66 nonapeptide from influenza virus matrix protein. Eur J Biochem (1992) 0.92
Relevance relations for the concept of reproducibility. J R Soc Interface (2014) 0.90
A fast method for obtaining highly pure recombinant herpes simplex virus type 1 thymidine kinase. Protein Expr Purif (1994) 0.90
Review of theoretical passive drug absorption models: historical background, recent developments and limitations. Pharm Acta Helv (1996) 0.90
PYY3-36 as an anti-obesity drug target. Obes Rev (2005) 0.90
Synthetic S-(2,3-dihydroxypropyl)-cysteinyl peptides derived from the N-terminus of the cytochrome subunit of the photoreaction centre of Rhodopseudomonas viridis enhance murine splenocyte proliferation. J Pept Sci (1997) 0.89
Neuropeptide Y and the nonpeptide antagonist BIBP 3226 share an overlapping binding site at the human Y1 receptor. Mol Pharmacol (1996) 0.88
Molecular dynamics of the alpha-helical epitope of a novel synthetic lipopeptide foot-and-mouth disease virus vaccine. Biopolymers (1989) 0.88
Nucleoside binding site of herpes simplex type 1 thymidine kinase analyzed by X-ray crystallography. Proteins (2000) 0.87
Radiometal targeted tumor diagnosis and therapy with peptide hormones. Curr Pharm Des (2008) 0.87
Novel analogues of neuropeptide Y with a preference for the Y1-receptor. Eur J Biochem (2001) 0.87
Use of fluorescence polarization to monitor MHC-peptide interactions in solution. J Immunol Methods (2001) 0.87
Millisecond to microsecond time scale dynamics of the retinoid X and retinoic acid receptor DNA-binding domains and dimeric complex formation. Biochemistry (1999) 0.85
Density functional studies on herpes simplex virus type 1 thymidine kinase-substrate interactions: the role of Tyr-172 and Met-128 in thymine fixation. Proteins (1998) 0.85
Folding and self-assembly of herpes simplex virus type 1 thymidine kinase. J Mol Biol (2001) 0.85
Antibodies to the protein core of the small cell lung cancer workshop antigen cluster-w4 and to the leucocyte workshop antigen CD24 recognize the same short protein sequence leucine-alanine-proline. Clin Exp Immunol (1993) 0.85
Increased risk of cervical abnormalities among HIV-infected African women. NIAID AIDS Agenda (1996) 0.85
Beta-amino acid scan of a class I major histocompatibility complex-restricted alloreactive T-cell epitope. J Biol Chem (2001) 0.85
Neuropeptide Y(5) receptors reduce synaptic excitation in proximal subiculum, but not epileptiform activity in rat hippocampal slices. J Neurophysiol (2000) 0.85
Nucleotide-binding properties of adenylate kinase from Escherichia coli: a molecular dynamics study in aqueous and vacuum environments. J Comput Aided Mol Des (1994) 0.85
Kinetics and crystal structure of the wild-type and the engineered Y101F mutant of Herpes simplex virus type 1 thymidine kinase interacting with (North)-methanocarba-thymidine. Biochemistry (2000) 0.85
Molecular modeling of an antigenic complex between a viral peptide and a class I major histocompatibility glycoprotein. Proteins (1992) 0.84
Immunocytochemical localization of angiotensin II receptor subtypes and angiotensin II with monoclonal antibodies in the rat adrenal gland. Regul Pept (2001) 0.83
99mTc-labeled neuropeptide Y analogues as potential tumor imaging agents. Bioconjug Chem (2001) 0.82
New [99mTc]bombesin analogues with improved biodistribution for targeting gastrin releasing-peptide receptor-positive tumors. Q J Nucl Med Mol Imaging (2007) 0.82
A new pharmophoric model for 5-HT reuptake-inhibitors: differentiation of amphetamine analogues. Pharm Acta Helv (1994) 0.82
On the role of thymopoietins in cell proliferation. Immunochemical evidence for new members of the human thymopoietin family. Biol Chem (1999) 0.82
CGRP 27-37 analogues with high affinity to the CGRP1 receptor show antagonistic properties in a rat blood flow assay. Regul Pept (1999) 0.81
Cloning and functional expression of the guinea pig neuropeptide Y Y2 receptor. Regul Pept (1998) 0.81
Y-receptor affinity modulation by the design of pancreatic polypeptide/neuropeptide Y chimera led to Y(5)-receptor ligands with picomolar affinity. Peptides (2001) 0.81
The rational of catalytic activity of herpes simplex virus thymidine kinase. a combined biochemical and quantum chemical study. J Biol Chem (2001) 0.81
A rational approach for the development of reduced-size analogues of neuropeptide Y with high affinity to the Y1 receptor. J Pept Sci (1997) 0.81
Compulsory order of substrate binding to herpes simplex virus type 1 thymidine kinase. A calorimetric study. J Biol Chem (2000) 0.81
Further characterization of neuropeptide Y receptor subtypes using centrally truncated analogs of neuropeptide Y: evidence for subtype-differentiating effects on affinity and intrinsic efficacy. Mol Pharmacol (1992) 0.81
Molecular characterization of the ligand-receptor interaction of neuropeptide Y. Curr Med Chem (1999) 0.80
Unusual stereospecificity of the potential antidepressant rolipram on the cyclic AMP generating system from rat brain cortex. Pharmacopsychiatry (1988) 0.80
Y1 receptors in the nucleus accumbens: ultrastructural localization and association with neuropeptide Y. J Neurosci Res (1998) 0.80
Rational design of nonnatural peptides as high-affinity ligands for the HLA-B*2705 human leukocyte antigen. Proc Natl Acad Sci U S A (1995) 0.80
Probing of the neuropeptide Y-Y1-receptors interaction with anti-receptor antibodies. Eur J Biochem (1998) 0.80
Differently labeled peptide ligands for rapid investigation of receptor expression on a new human glioblastoma cell line. Peptides (2000) 0.80
Cytotoxic and antibacterial dihydrochalcones from Piper aduncum. J Nat Prod (1994) 0.79
Biophysical methods to study ligand-receptor interactions of neuropeptide Y. Biopolymers (2001) 0.79
Peptide binding and photo-crosslinking to detergent solubilized and to reconstituted transporter associated with antigen processing (TAP). FEBS Lett (1997) 0.79
A new method for quantitative determination of tritium-labeled nucleoside kinase products adsorbed on DEAE-cellulose. Biochem Biophys Res Commun (1996) 0.79
Role of a hydrophobic pocket of the human Y1 neuropeptide Y receptor in ligand binding. Mol Cell Endocrinol (1995) 0.79
Thermodynamic stability of HLA-B*2705. Peptide complexes. Effect of peptide and major histocompatibility complex protein mutations. J Biol Chem (2000) 0.79
On the synthesis of orexin A: a novel one-step procedure to obtain peptides with two intramolecular disulphide bonds. J Pept Sci (2000) 0.79
Immune system activation boosts HIV replication in HIV-infected people. NIAID AIDS Agenda (1996) 0.79
Manipulating Y receptor subtype activation of short neuropeptide Y analogs by introducing carbaboranes. Neuropeptides (2013) 0.78
Understanding the selectivity of fumagillin for the methionine aminopeptidase type II. Oncol Res (2003) 0.78
Fine specificity of antigen binding to two class I major histocompatibility proteins (B*2705 and B*2703) differing in a single amino acid residue. J Comput Aided Mol Des (1997) 0.78
Three-dimensional model of the cyclin-dependent kinase 1 (CDK1): Ab initio active site parameters for molecular dynamics studies of CDKS. Proteins (2001) 0.78
Modified, cyclic dodecapeptide analog of neuropeptide Y is the smallest full agonist at the human Y2 receptor. FEBS Lett (1996) 0.78
Characterisation of G-protein-coupled receptors by antibodies. Curr Med Chem (2000) 0.78
Inhibition of Ca2+ channel currents in human neuroblastoma (SH-SY5Y) cells by neuropeptide Y and a novel cyclic neuropeptide Y analogue. Neuropharmacology (1995) 0.78
Two new protease inhibitors approved by FDA. Food and Drug Administration. NIAID AIDS Agenda (1996) 0.78
Modulatory effect of two novel CGRP receptor antagonists on nasal vasodilatatory responses to exogenous CGRP, capsaicin, bradykinin and histamine in anaesthetised pigs. Regul Pept (2001) 0.78
Structure-activity relationships of cannabinoids: a joint CoMFA and pseudoreceptor modelling study. J Comput Aided Mol Des (1997) 0.77
Highly purified recombinant varicella Zoster virus thymidine kinase is a homodimer. Protein Expr Purif (2000) 0.77
Studies of the human, rat, and guinea pig Y4 receptors using neuropeptide Y analogues and two distinct radioligands. Peptides (2001) 0.77
A new approach to secondary structure evaluation: secondary structure prediction of porcine adenylate kinase and yeast guanylate kinase by CD spectroscopy of overlapping synthetic peptide segments. Biopolymers (1997) 0.77